The negative effects of statin drugs on cardiomyocytes: current review of laboratory and experimental data (mini-review).

Statin drugs have long been used as a key component of lipid-lowering therapy, which is necessary for the prevention and treatment of atherosclerosis and cardiovascular diseases. Many studies focus on finding and refining new effects of statin drugs. In addition to the main lipid-lowering effect (blocking cholesterol synthesis), statin drugs have a number of pleiotropic effects, including negative effects. The main beneficial effects of statin drugs on the components of the cardiovascular system are: anti-ischemic, antithrombotic, anti-apoptotic, antioxidant, endothelioprotective, anti-inflammatory properties, and a number of other beneficial effects. Due to these effects, statin drugs are considered one of the main therapeutic agents for the management of patients with cardiovascular pathologies. To date, many review manuscripts have been published on the myotoxicity, hepatotoxicity, nephrotoxicity, neurotoxicity and diabetogenic effects of statins. However, there are no review manuscripts considering the negative effect of statin drugs on myocardial contractile cells (cardiomyocytes). The purpose of this review is to discuss the negative effects of statin drugs on cardiomyocytes. Special attention is paid to the cardiotoxic action of statin drugs on cardiomyocytes and the mechanisms of increased serum levels of cardiac troponins. In the process of preparing this review, a detailed analysis of laboratory and experimental data devoted to the study of the negative effects of statin drugs on cardiomyocytes was carried out. The literature search was carried out with the keywords: statin drugs, negative effects, mechanisms, cardiac troponins, oxidative stress, apoptosis. Thus, statin drugs can have a number of negative effects on cardiomyocytes, in particular, increased oxidative stress, endoplasmic reticulum stress, damage to mitochondria and intercalated discs, and inhibition of glucose transport into cardiomyocytes. Additional studies are needed to confirm and clarify the mechanisms and clinical consequences of the negative effects of statin drugs on cardiomyocytes.

• Publication year

  2023

• Venue

  Cardiovascular & Hematological Agents in Medicinal Chemistry

• Publication date

  2023-03-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1871525721666230314101019PMID 36918788
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biology of Cardiac Troponins: Emphasis on Metabolism

  2022cited by this paper
• False-Positive Causes in Serum Cardiac Troponin Levels

  2022cited by this paper
• Statins for the Prevention of Cardiovascular Disease.

  2022cited by this paper
• Atorvastatin Induces Mitochondria-Dependent Ferroptosis via the Modulation of Nrf2-xCT/GPx4 Axis

  2022cited by this paper
• Cardiac Troponins: Contemporary Biological Data and New Methods of Determination

  2021cited by this paper
• Elevation Mechanisms and Diagnostic Consideration of Cardiac Troponins under Conditions Not Associated with Myocardial Infarction. Part 2

  2021cited by this paper
• Cardiac Troponins Metabolism: From Biochemical Mechanisms to Clinical Practice (Literature Review)

  2021cited by this paper
• Clinical and Diagnostic Value of Highly Sensitive Cardiac Troponins in Arterial Hypertension

  2021cited by this paper
• Urine High-Sensitivity Troponin I Predict Incident Cardiovascular Events in Patients with Diabetes Mellitus

  2020cited by this paper
• Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways

  2020cited by this paper
• Short-term biological variation and diurnal rhythm of cardiac troponin I (Access hs-TnI) in healthy subjects.

  2020cited by this paper
• An Update on the Role of PCSK9 in Atherosclerosis

  2020cited by this paper
• Unexpected Troponin Elevation in a Patient Treated with Atorvastatin.

  2020cited by this paper
• [Molecular mechanisms of the cardiotoxic action of anthracycline antibiotics and statin-induced cytoprotective reactions of cardiomyocytes].

  2020cited by this paper
• [Circadian rhythms of thyroid hormones in patients with ischemic heart disease, arterial hypertension, and atrial fibrillation].

  2019cited by this paper
• [Clinical and Diagnostic Value of Cardiac Markers in Human Biological Fluids].

  2019cited by this paper
• Statins and the potential for higher diabetes mellitus risk

  2019cited by this paper
• Diabetogenic Action of Statins: Mechanisms

  2019cited by this paper
• Atorvastatin, but not pravastatin, inhibits cardiac Akt/mTOR signaling and disturbs mitochondrial ultrastructure in cardiac myocytes

  2018cited by this paper
• Impact of statin use on high sensitive troponin T levels with moderate exercise

  2018cited by this paper
• Fast skeletal troponin I, but not the slow isoform, is increased in patients under statin therapy: a pilot study

  2018cited by this paper
• Global Adoption of High-Sensitivity Cardiac Troponins and the Universal Definition of Myocardial Infarction

  2018cited by this paper
• PCSK9 Inhibitors: Novel Therapeutic Strategies for Lowering LDLCholesterol.

  2018cited by this paper
• Science Moves Slowly.

  2018cited by this paper
• Elevated Cardiac Troponin T in Patients With Skeletal Myopathies.

  2018cited by this paper
• Ultrasensitive quantification of cardiac troponin I by a Single Molecule Counting method: analytical validation and biological features.

  2018cited by this paper
• Economic Evaluation of PCSK9 Inhibitors in Reducing Cardiovascular Risk from Health System and Private Payer Perspectives

  2017cited by this paper
• Sex-specific 99th percentiles derived from the AACC Universal Sample Bank for the Roche Gen 5 cTnT assay: Comorbidities and statistical methods influence derivation of reference limits.

  2017cited by this paper
• Effects of Evolocumab on Cardiovascular Events

  2017cited by this paper
• High-sensitivity assays for troponin in patients with cardiac disease

  2017cited by this paper
• Hepatotoxicity associated with statins

  2017cited by this paper
• Circadian rhythm of blood cardiac troponin T concentration

  2017cited by this paper
• Long-term treatment adherence to the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab in 6 ODYSSEY Phase III clinical studies with treatment duration of 1 to 2 years.

  2017cited by this paper
• Cholesterol is required for maintaining T-tubule integrity and intercellular connections at intercalated discs in cardiomyocytes.

  2016cited by this paper
• Muscle- and skeletal-related side-effects of statins: tip of the iceberg?

  2016cited by this paper
• Elevated Plasma Cardiac Troponin T Levels Caused by Skeletal Muscle Damage in Pompe Disease

  2016cited by this paper
• Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force

  2016cited by this paper
• Effect of Three Statins on Glucose Uptake of Cardiomyocytes and its Mechanism

  2016cited by this paper
• The diabetogenic action of statins — mechanisms and clinical implications

  2016cited by this paper
• [Possibility of using saliva as a diagnostic test material in cardiovascular diseases].

  2015cited by this paper
• Statins and cognitive side effects: what cardiologists need to know.

  2015cited by this paper
• Statins and their increased risk of inducing diabetes

  2015cited by this paper
• The role of mitochondria in statin‐induced myopathy

  2015cited by this paper
• Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay.

  2014cited by this paper
• The pharmacology of statins.

  2014cited by this paper
• Statin treatment and new-onset diabetes: a review of proposed mechanisms.

  2014cited by this paper
• The antithrombotic effects of statins.

  2014cited by this paper
• Impact of statin use on exercise-induced cardiac troponin elevations.

  2014cited by this paper
• Salivary high-sensitivity cardiac troponin T levels in patients with acute myocardial infarction.

  2013cited by this paper
• Comparative effects of statins on murine cardiac gene expression profiles in normal mice.

  2013cited by this paper
• Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts

  2012cited by this paper
• Lipid-lowering drug therapy in elderly patients.

  2011cited by this paper
• The Anti-Ischemic and Anti-Anginal Properties of Statins

  2010cited by this paper
• A historical perspective on the discovery of statins

  2010cited by this paper
• Stents and statins: history, clinical outcomes and mechanisms

  2010cited by this paper
• MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice.

  2010cited by this paper
• Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

  2010cited by this paper
• Statin‐Associated Muscle‐Related Adverse Effects: A Case Series of 354 Patients

  2010cited by this paper
• Toxicity of statins on rat skeletal muscle mitochondria

  2006cited by this paper
• The discovery and development of HMG-CoA reductase inhibitors. 1992.

  2004cited by this paper
• ANTI‐APOPTOTIC EFFECT OF ATORVASTATIN, A 3‐HYDROXY‐3‐METHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR, ON CARDIAC MYOCYTES THROUGH PROTEIN KINASE C ACTIVATION

  2004cited by this paper
• Synthetic Statins: More Data on Newer Lipid-lowering Agents

  2001cited by this paper
• Desmin Cytoskeleton Linked to Muscle Mitochondrial Distribution and Respiratory Function

  2000cited by this paper
• Expression of messenger RNA of the cardiac isoforms of troponin T and I in myopathic skeletal muscle.

  2000cited by this paper
• RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle.

  1999cited by this paper
• Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients.

  1989cited by this paper
• Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction.

  1987cited by this paper
• [Life and career of N. N. Anichkov--outstanding Soviet pathologist (on the 30th anniversary of the electron of N. N. Anichkov to the presidency of the Academy of Medical Sciences of the USSR)].

  1977cited by this paper
• [Development of the ideas of N. N. Anichkov at the present stage of our knowledge about atherosclerosis].

  1975cited by this paper

• No citing papers are available for this paper.